Department of Internal Medicine, Telemark Hospital Trust, Skien, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Front Immunol. 2023 Oct 2;14:1253991. doi: 10.3389/fimmu.2023.1253991. eCollection 2023.
Early graft loss following kidney transplantation is mainly a result of acute rejection or surgical complications, while long-term kidney allograft loss is more complex. We examined the association between systemic inflammation early after kidney transplantation and long-term graft loss, as well as correlations between systemic inflammation scores and inflammatory findings in biopsies 6 weeks and 1 year after kidney transplantation.
We measured 21 inflammatory biomarkers 10 weeks after transplantation in 699 patients who were transplanted between 2009 and 2012 at Oslo University Hospital, Rikshospitalet, Norway. Low-grade inflammation was assessed with predefined inflammation scores based on specific biomarkers: one overall inflammation score and five pathway-specific scores. Surveillance or indication biopsies were performed in all patients 6 weeks after transplantation. The scores were tested in Cox regression models.
Median follow-up time was 9.1 years (interquartile range 7.6-10.7 years). During the study period, there were 84 (12.2%) death-censored graft losses. The overall inflammation score was associated with long-term kidney graft loss both when assessed as a continuous variable (hazard ratio 1.03, 95% CI 1.01-1.06, = 0.005) and as a categorical variable (4 quartile: hazard ratio 3.19, 95% CI 1.43-7.10, = 0.005). In the pathway-specific analyses, fibrogenesis activity and vascular inflammation stood out. The vascular inflammation score was associated with inflammation in biopsies 6 weeks and 1 year after transplantation, while the fibrinogenesis score was associated with interstitial fibrosis and tubular atrophy.
In conclusion, a systemic inflammatory environment early after kidney transplantation was associated with biopsy-confirmed kidney graft pathology and long-term kidney graft loss. The systemic vascular inflammation score correlated with inflammatory findings in biopsies 6 weeks and 1 year after transplantation.
肾移植后早期移植物丢失主要是由于急性排斥反应或手术并发症引起的,而长期肾移植丢失则更为复杂。我们研究了肾移植后早期全身炎症与长期移植物丢失之间的关系,以及全身炎症评分与肾移植后 6 周和 1 年活检中炎症发现之间的相关性。
我们在挪威奥斯陆大学医院 Rikshospitalet 于 2009 年至 2012 年间接受移植的 699 名患者中,在移植后 10 周测量了 21 种炎症生物标志物。根据特定生物标志物,使用预先定义的炎症评分来评估低度炎症:一个总体炎症评分和五个途径特异性评分。所有患者在移植后 6 周进行监测或指征活检。在 Cox 回归模型中测试评分。
中位随访时间为 9.1 年(四分位距 7.6-10.7 年)。在研究期间,有 84 例(12.2%)死亡相关移植物丢失。总体炎症评分与长期肾移植丢失相关,无论是作为连续变量(危险比 1.03,95%置信区间 1.01-1.06, = 0.005)还是作为分类变量(4 四分位:危险比 3.19,95%置信区间 1.43-7.10, = 0.005)。在途径特异性分析中,纤维化活性和血管炎症引人注目。血管炎症评分与移植后 6 周和 1 年的活检炎症相关,而纤维蛋白溶解评分与间质纤维化和肾小管萎缩相关。
总之,肾移植后早期全身性炎症环境与活检证实的肾移植病理和长期肾移植丢失相关。全身血管炎症评分与移植后 6 周和 1 年活检中的炎症发现相关。